West Boca Medical Center Opens New Interventional Vascular Imaging Suite

What To Know

  • This $4 million dollar investment will allow West Boca Medical Center to partner with sister hospital Delray Medical Center to expand its vascular services and offer patients this specialized care and technology in the community.
  • “We are excited to bring this enhanced level of interventional and vascular capabilities to our patients that can be accessed right here in their community,” said George Rizzuto, chief executive officer of West Boca Medical Center.

West Boca Medical Center increases its services in the community by offering patients advanced vascular and interventional imaging procedures in its new imaging suite and interventional radiology lab.

The new lab will add the Siemens Artis Q system to enhance imaging and invasive services. The system features high-resolution capabilities, which enhance minimally invasive therapies for peripheral vascular disease, embolization, and diagnostic examination.

“We are excited to bring this enhanced level of interventional and vascular capabilities to our patients that can be accessed right here in their community,” said George Rizzuto, chief executive officer of West Boca Medical Center.  “Our first priority is to deliver the highest quality and safest treatments to our patients.  These services and this new lab demonstrates our commitment by continuing to bring the most current technology and resources to Palm Beach County.”

Some of the benefits of this new technology include:

  • Superior image quality that provides better visualization of small vessels, devices, and tissue.
  • Enhanced system efficiency to produce the highest image quality at the lowest possible doses.
  • Improved interventional imaging for treatment of peripheral vascular disease.
  • Ability to perform rotational imaging for 3D reconstruction and vascular road mapping.
  • Integration of other imaging modalities, including CT and ultrasound, that provides a basis for planning therapies, such as embolization of tumors.

This $4 million dollar investment will allow West Boca Medical Center to partner with sister hospital Delray Medical Center to expand its vascular services and offer patients this specialized care and technology in the community.  For more information go to www.westbocamedctr.com or call 561-488-8000.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

X-Therma notes this DMF covers the Chemistry, Manufacturing and Controls (CMC) for this key chemistry innovation, which enables non-toxic cryopreservation for life-saving regenerative medicines.
Simpson Interventions is committed to collaborating closely with the FDA and other stakeholders to advance the development and regulatory review of the Acolyte Image Guided Crossing and Re-Entry Catheter System. The company looks forward to bringing this revolutionary technology to clinicians, and patients in need.
"The U.S. approval of TriClip is a significant advancement for people suffering from tricuspid regurgitation, a heart condition that negatively impacts their quality of life and puts them at grave risk of serious health issues," said Paul Sorajja, M.D., the Roger L. and Lynn C. Headrick Family Chair of the Valve Science Center for the Minneapolis Heart Institute Foundation and director of the Center for Valve and Structural Heart Disease for the Minneapolis Heart Institute at Abbott Northwestern Hospital and co-principal investigator of the TRILUMINATE™ Pivotal trial. "With TriClip, physicians can offer patients a therapy option backed by excellent safety and effectiveness to help restore tricuspid native valve performance without subjecting them to high-risk open-heart surgery that may not be feasible for individuals with TR who are generally older and sicker."
This make it one of the only wearable OTC anti-migraine device that is available without a prescription in the U.S.
NanoDrop has received clearance in the United States as the inaugural blood-lancing device available for over-the-counter use on the upper arm. This development is poised to revolutionize the consumer testing market and decentralized clinical trials within the realm of at-home healthcare.

By using this website you agree to accept Medical Device News Magazine Privacy Policy